FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On June 23, 2004
Table of Contents
Docket # Title
1995S-0117 Human Drugs Patent Term Extension & New Patents
2002N-0278 Bioterrorism; Prior Notice of Imported Food Shipments
2003D-0571 Guidance for Industry on Drug Substance; Chemistry, Manufacturing, and Controls Information
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003P-0274 In re Tier 1 initial Approval Program
2003P-0574 Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
2004D-0188 Guidance for Industry on Development and Use of Risk Minimization Action Plans
2004N-0086 Diabetes: Targeting Safe and Effective Prevention and Treatment; Public Meeting
2004N-0115 Prescription Drug Importation Study
2004N-0133 Part 11, Electronic Record; Electronic Signatures; Public Meeting
2004N-0221 Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Section 107(f) b
2004P-0171 Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
1995S-0117 Human Drugs Patent Term Extension & New Patents
LST 93 List as of June 22, 2004 Vol #: 7
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EC 802 N/A Vol #: 163
2002N-0278 Bioterrorism; Prior Notice of Imported Food Shipments
EC 489 Mrs. Pilar Guerrero Roldan Vol #: 29
EC 490 Mr. Rob Pounds Vol #: 29
EC 491 Always Canadian, LLC Vol #: 29
EC 492 Alaska Marine Lines,Inc. Vol #: 29
2003D-0476 Guidance for Industry on Product Recalls, Including Removals and Corrections; Availability
EC 4 Mr. Steve Dotson Vol #: 1
2003D-0571 Guidance for Industry on Drug Substance; Chemistry, Manufacturing, and Controls Information
EC 3
Attachment
SCHWARZ PHARMA AG Vol #: 1
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EC 29 none Vol #: 7
EC 30 Dr. Ted Labuza Vol #: 7
EC 31 Ms. Mary Jo Shank Vol #: 7
EC 32 Mr. Joseph Wetzel Vol #: 7
EC 33 Mrs. Elizabeth Dehart Vol #: 7
EC 34
Attachment
Frito-Lay, North America Vol #: 1
EMC 228 National Dairy Council (NDC) Vol #: 7
2003P-0274 In re Tier 1 initial Approval Program
EMC 40 Abigail Alliance Vol #: 4
2003P-0574 Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
EMC 3 C. Hornback Vol #: 2
2004D-0188 Guidance for Industry on Development and Use of Risk Minimization Action Plans
EMC 3 CenterFIRST Vol #: 1
2004N-0086 Diabetes: Targeting Safe and Effective Prevention and Treatment; Public Meeting
EMC 17 I. Robinett,RN,BSN,CDE,CPT Vol #: 1
EMC 18 G. Lorenzi, RN, CDE Vol #: 1
EMC 19 G. Lorenzi, RN, CDE Vol #: 1
EMC 20 J. Byers Vol #: 1
EMC 21 S. Strosnider Vol #: 1
EMC 22 M. Schenk Vol #: 1
2004N-0115 Prescription Drug Importation Study
EMC 21 Pharmaceutical Security Institute (PSI) Vol #: 19
EMC 22 META Solutions, Inc. Vol #: 19
2004N-0133 Part 11, Electronic Record; Electronic Signatures; Public Meeting
EC 16
Attachment
AstraZeneca plc Vol #: 1
EC 17 CRF inc. Vol #: 1
EMC 40 Syngenta Limited, Alderley Park Vol #: 4
EMC 41 PHT Corporation Vol #: 4
2004N-0221 Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Section 107(f) b
EMC 4 T. Florence Vol #: 1
EMC 5 MINOPS ProjectJudith Taylor Vol #: 1
2004P-0171 Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
EMC 1 Biotechnology Industry Organization (BIO) Vol #: 1

Page created on June 24, 2004 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management